Related Experiment Videos
[Efficacy of anti-digoxin antibodies in a premature neonate]
A Menget1, A Burguet, C Fromentin
1Service de Réanimation Infantile Polyvalente et Prématurés, CHU, Besançon.
Archives Francaises De Pediatrie
|November 1, 1989
Insights
Severe digitalis intoxication in premature infants can be effectively treated with anti-digoxin antibodies. This life-saving therapy has not previously been utilized in premature neonates.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Toxicology
Background:
- Digitalis glycosides are commonly used for treating heart conditions in neonates.
- Premature infants, particularly those born extremely preterm, present unique pharmacokinetic challenges.
- Severe digitalis toxicity poses a significant risk in this vulnerable population.
Observation:
- A case report details severe digitalis intoxication in an extremely premature infant (27 weeks gestation, 800g birthweight).
- The infant's condition necessitated urgent and effective intervention.
- Standard treatment protocols may have limitations in extremely preterm neonates.
Findings:
- Administration of anti-digoxin antibodies was highly efficacious in reversing the severe digitalis intoxication.
- This represents the first documented use of anti-digoxin antibodies for digitalis toxicity in an extremely premature infant.
- Rapid and complete recovery was observed following antibody administration.
Implications:
- Anti-digoxin antibodies should be considered a crucial therapeutic option for managing digitalis toxicity in premature neonates.
- This case expands the known applications of anti-digoxin antibodies to extremely preterm infants.
- Further research into the safety and efficacy of anti-digoxin antibodies in neonatal populations is warranted.
Abstract:
Through the case report of severe digitalis intoxication in a premature born after 27 weeks of gestation with a birthweight of 800 g, the authors show that anti-digoxin antibodies constitute a very efficacious therapeutic tool which, up to the present, has not been used in prematures.